Anondita Medi.
NSE: ANONDITA · Personal Care
Snapshot
Unlock Anondita Medi.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Anondita Medicare Limited is a personal care company specialising in the manufacturing of flavoured male and female condoms. Its primary product line is marketed under the flagship brand name 'COBRA'.
Business Model
The company generates revenue through the manufacturing, printing, and packaging of contraceptive products. It ensures quality control through 100% electronic testing of its inventory.
- Flagship Brand:COBRA
Growth Outlook
Growth is expected to be driven by the expansion of its product portfolio to include female condoms alongside its established male condom offerings.
Key Risks
- Regulatory Compliance. The company operates in a highly regulated sector requiring strict adherence to health and safety standards for medical devices.
- Market Competition. The personal care and contraceptive market is highly competitive, featuring both established multinational brands and low-cost local players.
- Operational Risks. As a manufacturer, the company is susceptible to supply chain disruptions and fluctuations in the cost of raw materials used in condom production.
Start your research today
Unlock AI insights, financials, peers and live data on Anondita Medi. and 5,000+ companies — free.
Peers · Personal Care
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Anondita Medi.ANONDITA | ₹2,085 Cr | — | — | — | 37.0% | — | — | +188.4% |
Procter & Gamble Hygiene & Health Care Ltd.PGHH | ₹23,351 Cr | 27.3× | 20.37 | 25.6% | 26.4% | 106.1% | 125.6% | -53.0% |
Gillette India Ltd.GILLETTE | ₹23,116 Cr | 33.7× | 23.15 | 38.3% | 31.1% | 67.8% | 83.2% | -28.1% |
Emami Ltd.EMAMILTD | ₹17,087 Cr | 21.7× | 16.10 | 2.8% | 27.0% | 26.7% | 30.3% | -31.3% |
Honasa Consumer Ltd.HONASA | ₹15,809 Cr | 56.0× | 40.99 | 21.1% | 15.0% | 19.2% | 23.6% | +49.3% |
Bajaj Consumer Care LimitedBAJAJCON | ₹6,607 Cr | 29.8× | 22.62 | 25.8% | 23.5% | 29.7% | 36.0% | +110.6% |
As of Mar 2026
Financials
Anondita Medi.
NSE: ANONDITA · Personal Care
Snapshot
Unlock Anondita Medi.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Anondita Medicare Limited is a personal care company specialising in the manufacturing of flavoured male and female condoms. Its primary product line is marketed under the flagship brand name 'COBRA'.
Business Model
The company generates revenue through the manufacturing, printing, and packaging of contraceptive products. It ensures quality control through 100% electronic testing of its inventory.
- Flagship Brand:COBRA
Growth Outlook
Growth is expected to be driven by the expansion of its product portfolio to include female condoms alongside its established male condom offerings.
Key Risks
- Regulatory Compliance. The company operates in a highly regulated sector requiring strict adherence to health and safety standards for medical devices.
- Market Competition. The personal care and contraceptive market is highly competitive, featuring both established multinational brands and low-cost local players.
- Operational Risks. As a manufacturer, the company is susceptible to supply chain disruptions and fluctuations in the cost of raw materials used in condom production.
Start your research today
Unlock AI insights, financials, peers and live data on Anondita Medi. and 5,000+ companies — free.
Peers · Personal Care
As of Mar 2026